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Rheumatoid factors (RF),' autoantibodies that bind to the Fc fragmentofIgG,
were first identified in the sera ofpatients with rheumatoid arthritis (RA; 1, 2).
The presence of RF has since been shown in the sera of patients with other
rheumatic diseases (3) and with a variety ofother chronic or infectious diseases
such as subacute bacterial endocarditis, tuberculosis, and sarcoidosis (4-6). RF
associated with RA characteristically exhibita broadrangeofbindingspecificities
for homologous and heterologous IgGs, whereas RF associated with nonrheu-
matic diseases bind preferentially to human IgG (4).
RF production, a hallmark of RA, may contribute to tissue injury in this
disease. RF-containing immune complexes have been seen (7-9) in sera and
synovial fluids and within phagocytes of patients with RA. The capacity of IgG
and IgM RF to activate complement under experimental conditions (10), the
demonstration ofcomplement cleavage products in synovial fluids ofRA patients
(11), and evidence of local RE production at sites of tissue inflammation in RA
imply an active role for RF in tissue injury (12, 13).
Paradoxically, some evidence indicates that RF may represent normal com-
ponents of the immune system (14). The spontaneous appearance of anti-IgG
antibodies in the sera of unmanipulated normal mouse strains has been docu-
mented (15, 16). Moreover, RF have been identified during the course of
anamnestic responses to soluble antigens in mice (17-19) and man (20). Other
evidence suggests that RF may subserve a biologically significant role(s) in some
immune responses by amplifying the function of specific antibodies (21-23).
Little is known of the molecular events underlying the expression of RF in
either the pathologic orphysiologic situation. Clones producing RF in the setting
ofautoimmune disease may use a unique set of germline genes that are under
concerted regulation, or they may derive from the same germline pool as
antibodies directed against exogenous antigens. Since somatic mutational and
combinatorial events play an important role in determining antigen-binding
specificity, these mechanisms could permit the synthesis of pathologic RF from
the same germline repertoire that encodes responses to exogenous antigens. To
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explore the genetic basis of autoantibody expression, we have taken advantage
of the autoimmune mouse strain MRL/Mp lpr/lpr. This strain spontaneously
produces high titers of anti-IgG antibodies, with detectable amounts in the serum
as early as 6 wk of age (24). They also exhibit many clinical manifestations typical
of human RA, including synovial cell proliferation, pannus formation, and
eventual joint destruction (25, 26). Another advantage of using a mouse model
system is that the genes encoding the Ig V,, regions of antibodies have been
studied most extensively in mice, and they have been shown to be clustered
together into at least eight homologous family groups ranging in size from 2 to
50 or 60 members tandemly linked on chromosome 12. Genes within a family
share at least 75% homology, whereas genes of different families are usually
<70% homologous (27, 28).
We have generated a panel of anti-IgG mAbs from young MRL mice raised
under pathogen-free conditions by fusing unstimulated spleen cells with a non-
secreting myeloma. Our major goals were to determine the binding specificities
of each clone and to determine which V family encoded the antigen-binding
portion of antibodies produced by each clone. We found that the monoclonals
bound to different proteolytic fragments of IgG, to several IgG subclasses, and
to IgGfrom other mammalian speciesjust as do anti-IgG antibodies from patients
with RA . We hybridized probes representing gene segments from seven V,,
families with RNA from our anti-IgG clones, and we have found that one small
V family preferentially contributes the codes for these anti-IgG antibodies
regardless of the binding specificity.
These data indicate that the genetic codes for anti-IgG antibodies in young
MRL mice are restricted in their heterogeneity even though the antigen-binding
specificity is already heterogeneous. In addition, our finding that a single small
V family contributes the codes for most of our anti-IgG antibodies raises
questions concerning V,, gene expression and the regulation of that expression
in autoimmunity.
Materials and Methods
Mice.
￿
Breeder pairs of MRL/Mp lpr/lpr mice were obtained from Jackson Laborato-
ries (Bar Harbor, ME) and were bred and maintained in Trexler type isolators (Germ-
Free Supply Div., Standard Safety Equipment Co., Palatine, IL) until they were used in
experiments. All food, water, bedding, and cages were autoclaved and entered aseptically
into the isolators. Original breeders were later killed and screened for all common viral,
mycoplasmal, bacterial, and parasitic pathogens. We performedgrossand histopathologic
examinations of all major organs to check for lesions. Serologic tests were performed for
the following viruses: mouse hepatitis, Sendai, Theiler's poliomyelitis, minute virus of
mice, pneumonia virus of mice, reovirus 3, K virus, polyoma, mouse adenovirus, mouse
pox, mouse rotavirus, and lymphocytic choriomeningitis virus. Thereafter, representatives
from several age groups in each isolator were killed and screened twice annually to insure
pathogen-free status of the colony.
Hybridomas.
￿
Untreated spleen cells from 4-15-wk-old female MRL/Mp lpr/lpr mice
and a 32-wk-old MRL/Mp +/+ mouse were fused with X63-Ag8.653 nonsecreting
myeloma cells (29). The hybridomas were initially cultured in RPMI 1640 (Flow Labo-
ratories, Inc., McLean, VA) supplemented with 12% FCS (Flow Laboratories, Inc.),
glutamine (2.0 mM), MEM nonessential amino acids (0.01 mM), 2-ME (5 X 10-5 M), and
penicillin (100 U/ml), streptomycin (100 Wg/ml), andHAT(50X stock; Flow Laboratories,
Inc.). We screened culture supernatants from the resulting hybridomas for the presence1286
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of IgM or IgA antibodies reactive with purified mouse IgG (Cappel Laboratories, Coch-
ranville, PA) using an ELISA adaptation ofan RIA for RF (30). Plates (Costar, Cambridge,
MA) were coated with murine IgG at a concentration of 25 ug/ml overnight at 4°C and
then blocked with 0.15 M NaCl (pH 7.5) buffered with 0.02 M sodium phosphate (PBS)
containing 1% BSA (Sigma Chemical Co., St. Louis, MO). Wells coated with PBS/1
BSA served as a control. Undiluted culture supernatants (100 ,1) were added to wells and
incubated overnight at 4'C. After four rinses with PBS, we added 100 Al of alkaline
phosphatase-labeled goat antibody directed against IgM or IgA (Southern Biotechnology
Associates, Birmingham, AL; the specificity of each goat antisera was checked by ELISA
against IgG-, IgM-, and IgA-coated plates), incubated this for 6 h at room temperature,
and rinsed it five times with PBS. The assay was developed with 1 .0 mg/ml p-nitrophenyl
phosphate (Sigma Chemical Co.) in I M diethanolamine buffer (pH 9 .8) containing 0.5
MM MgCl2; after a 30 min development, the absorbance was read at 405 nm in a Titer
Tek Multiskan MC ELISA reader (Flow Laboratories, Inc.). Hybrids that exhibited strong
reactivity(OD >0 .8) with mouse IgG were cloned by limiting dilution in the same medium
used for fusions (without HAT) and subcloned a minimum of four more times until each
was stable.
Binding Assays.
￿
Binding of antibodies from selected cell hybrids to murine IgG sub-
classes, heterologous IgG, and proteolytic fragments of mouse IgG were analyzed as
follows. Monoclonal IgG subclass proteins used were IgGI (MOPC 21), IgG2a (UPC 10,
HOPC-1), IgG2b (MOPC 195) and IgG3 (J606) (Litton Bionetics, Charleston, SC). We
verified by ELISA that concentrations of all IgG subclasses coated onto the wells were
comparable. Fragments of polyclonal mouse IgG [Fc, Fab, (Fab')2] were obtained from
Jackson ImmunoResearch Laboratories (Avondale, PA) and were analyzed for purity by
immunodiffusion and RIA before use. Cat, horse, pig, rat, goat, rabbit, cow, and guinea
pig IgGs were purchased from Pel-Freeze Biologicals (Rogers, AR) and human IgG was
isolated from a pooled Cohn II fraction, as previously described (30). Polystyrene Immulon
2 Removawell strips (Dynatech Laboratories, Inc., Alexandria, VA) were coated overnight
at 4'C with the IgG preparations described above at 25 ug/ml or with goat anti-mouse
IgM at 2.5 ug/ml, and were subsequently blocked with PBS containing 1 % BSA for 1 h
at room temperature. IgM concentrations for each hybridoma culture supernatant were
determined by solid-phase RIA using the anti-IgM-coated plates and MOPC 104E as the
IgM standard. Binding studies with heterologous IgGs and murine IgG fragments were
done with each supernatant at concentrations ranging from 1 to 250 ng/ml of IgM.
Samples were incubated overnight at 4 ° C, rinsed four times with PBS, then incubated
overnight at 40 C with ` 251-labeled goat anti-mouse IgM (31). After extensive washing
with PBS, wells were counted in a gamma counter (Beckman Instruments, Inc., Fullerton,
CA).
All clones were also assayed for reactivity with double-stranded B-DNA (calf thymus
DNA; Worthington Biochemicals Corp., Freehold, NJ) and Z-DNA [brominated poly(dG-
dC)-poly(dG-dC)], a gift from Drs. Robert Bergen and Robert Wells (University of
Alabama at Birmingham). Single-stranded DNA was prepared by heating the double-
stranded calfthymus DNA in a boiling water bath for 10 min and plunging it immediately
into an ice-water bath to prevent reannealing. Polystyrene wells were precoated with 150
,,l (10 jug/ml) poly-L-lysine (Sigma Chemical Co.) for 1 h at room temperature, then were
coated with 150 Al of the appropriate DNA at a concentration of 2 .5 Ecg/ml for 4 h at
room temperature and then blocked with PBS containing 1 % BSA for 1 h. Plates precoated
with poly-L-lysine were blocked with poly-L-glutamate (50 Ag/ml) and used as controls.
Culture supernatants were added at IgM concentrations ranging from 10 to 1,000 ng/ml
and binding was determined by RIA.
RNA Extraction and Dot Blots.
￿
Viable hybridoma cellswere adjusted to 2 x 105 cells/ml.
10 ml were washed in ice-cold PBS, centrifuged, and the cell pellet was resuspended in
45 Al Tris/EDTA buffer (10 mM Tris, 1 mM EDTA [pH 7 .6]) containing 2,000 U/ml of
Ribonuclease Inhibitor (Sigma Chemical Co.). Samples were brought to 0.5% NP-40 with
gentle mixing on ice for 5 min and were centrifuged in Eppendorf tubes for 3 min toARANT ET AL.
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pellet nuclei and mitochondria. Supernatants (50 Al) were transferred to fresh tubes
containing 30 wl 20X SSC (1X SSC = 0.15 M NaCl, 0.015 M sodium citrate) and 20 AI
37% formaldehyde, and they were incubated at 65 ° C for 15 min. Samples were initially
diluted 1:10 in 15X SSC and serially diluted with a final dilution of 1 :320. Aliquots (100
Al) of each dilution were applied to BA85 nitrocellulose filter paper in a 96-well filtration
manifold (Schleicher & Schuell, Keene, NH). Filters were air-dried, baked for 2 h at 80°C
in vacuo, and prehybridized for 4 h at 42°C in buffer containing 50% formamide, 5X
SSC, 50 mM Na2HP04, 0.2% SDS, 100 tag/ml boiled salmon sperm DNA, 100 Ag/ml
heparin, and 5X Denhardt's solution (1X = 0.05% each of ficoll, polyvinylpyrrolidone,
and BSA). The hybridization buffer was the same but with a 1 X Denhardt's concentration
and 2 X 106 cpm/ml g2P-labeled probe. Hybridization of dot blots was done at 42'C for
16 h, followed by three low-stringency washes (2X SSC, 0.1% SDS, 0.1% sodium
pyrophosphate at 55'C) and three high-stringency washes (0.2X SSC, 0.1% SDS, 0 .1%
sodium pyrophosphate at 60°C). Filters were then blotted with paper towels, wrapped in
plastic wrap, and exposed to XAR-5 film (Eastman Kodak Co., Rochester, NY) at -70° C
using a Cronex Lightning-plus intensifying screen (DuPont Co., Wilmington, DE). Films
were developed after 18 or 24 h and filters not displaying hybridizations after this time
were reexposed for 48 h to allow low-homology hybridization to be detected.
Probes.
￿
Representatives from seven of the eight identified murine V families were
tested for hybridization to filters containing RNA from each clone. The probes used were
pSPV 81X (0.28 kb) from the 7183 family (32), pBSI07V (0.3 kb) from the S107 family
(33), pUVQ52 (0.3 kb) from the Q52 family (27), pBV J558 (1 .0 kb) from the J558
family (27), pBV J606 (0 .6 kb) from the J606 family, pB6.3R1 (2.3 kb) from the 36-60
family (34), 460-42 (0.22 kb) from the 36-60 family (34), and V 23-9 (0.4 kb) from the
3609 family (28). Since all clones were producing IgM, we used a cDNA probe repre-
senting the CA constant region, pBA, 2 (1 .0 kb), as a positive control (35).
All probe inserts were isolated from vectors by enzyme digestion, size fractionation by
agarose gel electrophoresis, electroelution into a 7.5 M ammonium acetate bridge (Inter-
national Biotechnologies Inc., New Haven, CT), and ethanol precipitation. Purified inserts
(50-100 ng) were nick-translated with g2P-deoxynucleotides (36) to a specific activity of
>10' cpm/pg, and they were added to the hybridization buffer at a concentration of 2 X
106 cpm/ml.
Densitometric Analyses.
￿
Autoradiograms of RNA dot blots were scanned with a 2202
Ultrascan laser densitometer and curves integrated with GELSCAN software (LKB
Instruments, Inc., Gaithersburg, MD) in an Apple He computer. Lanes showing hybridi-
zation with V probes were scanned and their hybridization intensities were compared
with the CA (constant region of the IgM) probe hybridization on the same filter. Filters
were stripped of each V probe in 80% formamide in distilled water for 30 min at 60 ° C,
were exposed to film overnight to insure that the stripping was complete, and were
rehybridized with the CA probe. All comparisons were performed at the same absorbance
on the same intensity scale at a scan speed of 100 mm/min. The actual intensities are
arbitrary units such that a full scale peak height of 10, with a full width at half maximum
of 1 .0, has an intensity of 1,000 U .
Results
Construction of Clones Secreting Anti-IgG Antibodies.
￿
Spleen cells from individ-
ual, unmanipulated pathogen-free female MRL/Mp lpr/lpr mice, ages 4, 8, 14,
and 15 wk and a 32-wk-old female of the congenic strain MRL/Mp +/+ were
fused with X63-Ag8.653 nonsecreting myeloma cells (29) and plated into ten
24-well tissue culture plates (240 wells per fusion). After 2-3 wk, hybrids
developed in 192 wells each from the 4 and 8 wk spleens, and 9.8% of the
hybrids secreted IgM antibodies directed against IgG. Hybrids developed in all
240 wells from both the 14 and 15 wk spleens, and 2.5% produced IgM directed
against mouse IgG. Fusion with the MRL/Mp +/+ spleen yielded 142 hybrids,1288
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TABLE I
Binding ofMonoclonal Anti-IgG to Proteolytic Cleavage Fragments ofMouse IgG
Data represent the percent binding to proteolytic fragments of mouse IgG compared with the
binding to mouse IgG. Percent binding = [(mean cpm proteolytic fragment - mean cpm BSA
control)/(mean cpm intact IgG - mean cpm BSA)] X 100 f [(SD of triplicates/mean of triplicates)
X 100].
* Age ofmice (wk) from which each clone was derived.
$ Both clones in GroupIII were IgM a. All otherclones were IgM K.
only 1 (0.7%) of which secreted IgM anti-IgG. Hybrids from each fusion that
showed the strongest reactivity with mouse IgG as determined by ELISA (OD
>0.8) were cloned by limiting dilution and subcloned at least four more times to
insure clonality and stability. Hybridomas generated from the MRL/Mp 1pr/lpr
mice were generally unstable and 60% were lost due to cell death, low cloning
efficiency, or loss of antibody production. Antigen-binding properties and IgM
concentrations ofsupernatants obtained from each initial cloningwere compared
with supernatants from each subclone to monitor against the selection of an
undesired mutant during the multiple reclonings.
Binding Specificities of Anti-IgG Hybridomas.
￿
MRL/Mp lpr/1pr mice develop
an arthritis with circulating RF similar to RA (25, 26). Since RF in the sera of
RA patients generally display a broader range of binding specificities than non-
RA-associated RF, we sought to determine whether or not our anti-IgG-produc-
ing clones from MRL mice had a broad or restricted range of antigen-binding
capabilities. We therefore tested the capacity of each monoclonal to bind to
different proteolytic cleavage fragments of IgG, subclasses of mouse IgG, and
IgG from other mammalian species.
IgG Fragments.
￿
The results of the binding studies with proteolytic cleavage
fragments of mouse IgG [Fc, Fab and (Fab')2] and intact pooled mouse IgG are
shown in Table I. Ages of the mice from which each clone was derived are also
noted. Two clones, 252H6 (15 wk) and 295A4 (14 wk), reacted strongly with
the Fc fragment of IgG but did not bind to other fragments. In contrast, clones
253B2 (15 wk) and 295C6 (14 wk) bound weakly to the Fc fragment and not to
other IgG fragments. Two clones, 146C6 (8 wk) and 154B5 (4 wk), bound
moderately to Fab and (Fab')2 fragments but not to Fc. Both of these clones
were IgM X, while all other clones were IgM K. Clone 294D6 (14 wk) bound to
(Fab')2 only and probably recognizes a determinant in or near the hinge region .
Group Clone Age* IgM (ng/ml) Fc Fab (Fab')2
I 252H6 15 100 90 ± 3.4
295A4 14 100 90 ± 2.8
II 253112 15 250 17 ± 1.2
295C6 14 250 19 ± 0.6
III 146C6t 8 500 - 48 t 9.3 24 ± 3.0
154115 4 500 - 39 ± 3.6 20 ± 5.0
IV 291C4 14 500 - - -
294D6 14 100 - - 99 ± 3.5
MRL +/+ 32 500 - - -ARANT ET AL .
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FIGURE 1 .
￿
Culture supernatants (100 ng/ml) from individual clones were added to microtiter
plates coated with mouse IgG (polyclonal) or monoclonal IgG subclasses . Histograms represent
mean cpm binding to IgG or subclasses after subtraction ofbackground binding of each sample
to BSA (<800 cpm in each case) . Assays were done in triplicate and standard deviations for
each sample were <5% of mean .
Two clones, 291C4 (14 wk) and MRL+/+ (32 wk), reacted with intact IgG only .
Based on this analysis, the clones could be divided conveniently into four groups .
Group I clones showed strong binding only to Fc, while group II clones bound
less avidly to Fc . GroupIII members reactedwith bothFaband (Fab')2 fragments,
and group IV members recognized only intact IgG or (Fab')2 .
Murine IgG Subclasses.
￿
Both clones in group I recognized IgG2a and IgG3,
and clone 2521-I6 also reacted with IgGI (Fig . 1A) . Group II clones each reacted
preferentially with IgG2a and IgG3 (Fig . 1 B) . Two members of group IV
displayed restricted bindingto a single but distinct subclass ; 291C4 preferentially1290
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TABLE II
Binding ofIgM Anti-IgG to Heterologous IgG
Data represent percent bindingto heterologous IgG compared with mouse IgG at the same concentrationof IgM (100 ng/ml) . Percent
binding = [(mean cpm heterologous IgG - mean cpm BSA control)/(mean cpm mouse IgG - mean cpm BSA control)] x 100 ± [(SD
of triplicates/mean of triplicates) x 100].
reacted with IgG2a, while MRL +/+ bound to IgG3 (Fig. I C). None ofthe anti-
IgG antibodies exhibited significant binding to IgG2b. Group III clones and
clone 294D6 of group IV did not show distinct subclass or L chain-associated
binding (data not shown).
Heterologous IgG.
￿
The binding of each monoclonal anti-IgG antibody to pig,
rat, human, horse, goat, cow, guinea pig, and rabbit IgG is shown in Table II.
Only one member of group 1, 252H6, reacted with heterologous IgG, and it
crossreacted weakly with only human IgG. The clones that made up group II
exhibited broad crossreactivity with heterologous IgG. In contrast, the members
of group III reacted only with homologous IgG. One member of group IV,
294D6, reacted with rabbit IgG, whereas the other members did not bind to
IgG ofany species tested. Thus, clones residing within the same group displayed
similar binding characteristics. These binding studies indicate that the members
of group II in our panel of anti-IgG antibodies possess a broad binding pattern
similar to RF in patients with RA, whereas members of the other groups show
more restricted binding patterns.
Reactivity of anti-IgG mAbs with DNA.
￿
In some autoimmune diseases, patients
synthesize antibodies directed against DNA, RNA, and/or protein-nucleic acid
complexes. In fact, some RF in RA crossreact with nucleic acids either alone or
as protein complexes (37). To determine whether or not any of our MRL anti-
IgG antibodies also displayed such crossreactivity, we used a solid-phase RIA to
test their reactivity with Z DNA (left-handed), B DNA (right-handed), and
denatured (single-stranded) DNA (Table III). A monoclonal IgM K hybridoma
antibody (Za) specific for Z DNA and generated from an MRL/Mp lpr/lpr mouse
served as a positive control.' The two clones in group I (295A4 and 252H6)
both reacted strongly with Z DNA, and one, 295A4, also recognized B DNA;
neither recognized single-stranded DNA. None of the other monoclonal anti-
IgG antibodies at concentrations of 1.0 jug/ml exhibited binding to DNA. Thus,
a subset ofour anti-IgG antibodies also exhibits crossreactivity with DNA.
'Bergen, H. R., M.J. Losman, T. O'Connor, W. Zacharias, J. E. Larson, R. D. Wells, and W. J.
Koopman. Anti-Z-DNA monoclonal antibodies from unimmunized MRL/Mp-lpr/lpr mice. Manu-
script submitted for publication.
Group Clone Pig Rat Goat Horse Human Rabbit Bovine Guinea Pig
I 252H6 - - - - 21 * 4.3
295A4 - - - - -
11 253B2 73±2 .4 75±4 .0 81±5 .6 87±2 .5 S1±4 .1 93±3 .9 80±3 .0 75±6 .5
295C6 73±3 .2 73±1 .8 78±2 .4 85±2 .1 86±2 .1 93±2 .2 84±5.0 74±5 .0
III 146C6
154115
IV 294D6 - - - - - 82 1 2.0
291C4 - - - - - -
MRL +/+ - - - - - -ARANT ET AL.
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TABLE III
Crossreactivity ofAnti-IgG with Various DNA
Microtiter wells were precoated with poly-L-lysine then coated with various DNA preparations at
2.5 wg/ml. Culture supernatants were diluted to 1,000; 250; and 100 ng IgM/ml and 100 til was
added to the plates. RIA was done in triplicates, and data represent (mean cpm with each DNA
preparation - mean cpm BSA control). SD for each triplicate set was <5% of total cpm in each
case.
* The positive control for Z DNA binding wasa monoclonal IgM-a (Za).
Identification of V  Gene Families that Encode Anti-IgG mAbs.
￿
Since the MRL
anti-IgG antibodies recognized a wide range ofantigenic determinants, it seemed
likely that they were encoded by manydifferent V gene segments. Todetermine
how diverse the codes for these V regions were, we hybridized probes from
seven of the eight known murine VH families with RNA extracted from each
clone (Figs. 2-4). In all cases, a probe for Cu was used as a positive control to
estimate the quantity ofH chain mRNApresent for each clone, and hybridization
intensities between CI and V were compared by laser densitometric scanning
of the autoradiographic films. Six clones hybridized with only the 36-60 V
family probes, pB6.3RI (2.3 kb) and 460-42 (0.22 kb). The histograms in Fig. 2
depict intensities of hybridization with the Cg probe and the 36-60 probes for
five of the six clones that hybridized exclusively with probes from the 36-60 VH
family. The numbers below each set of histograms represent the ratio of the
intensity of hybridization with the 36-60 probes to the intensity of hybridization
with the Cl probe. Filters hybridized with the CtL (1.0 kb) or pB6.3R1 (2.3 kb)
probes (Fig. 2, lower panel) were exposed 16 h, and the filter hybridized with the
460-42 (0.4 kb) probe (Fig. 2, upper panel) was exposed 48 h to compensate for
the differences in the lengths of the probes (probes <0.6 kb were exposed to
film for 48 h). All clones hybridized better with the pB6.3R1 probe than with
Group Clone IgM (ng/ml) Z DNA
Double-
stranded
DNA
Single-
stranded
DNA
anti-Z DNA* 50 21,562 582 357
100 26,846 529 565
250 30,494 612 784
I 2521-I6 100 10,219 828 499
250 17,359 1,014 1,037
295A4 100 26,890 20,180 429
250 35,065 29,924 1,020
II 253112 1,000 1,952 1,301 475
295C6 1,000 3,964 2,443 700
III 146C6 1,000 1,025 538 219
154115 1,000 687 373 371
IV 291C4 1,000 504 312 134
294D6 1,000 3,875 1,536 637
MRL +/+ 1,000 3,737 2,555 503
Background (nosample) 483 314 2101292
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FIGURE 2 .
￿
RNA was extracted from each clone and dot-blotted onto nitrocellulose filters .
Separate filters were used for hybridization with each V probe . After exposure to x-ray film,
16 h for pB6.3R1 and 48 h for 460-42, each filter was stripped, rehybridized with the CIa
probe, and exposed for 15 h . Densitometric scans were performed on autoradiograms and
intensities were calculated with the GELSCAN program . The histograms in the upper panel
represent hybridization intensities with the 460-42 and Cp probes and the histograms in the
lower panel represent hybridization intensities with the pB6.3R1 and Cu probes on a separate
filter . Numbers below each histogram represent (hybridization intensity with the V
probe/hybridization intensity with the Cu control probe) .
the 460-42 probe, as indicated by the intensity comparisons of the 36-60 probes
to the CA probe. Two clones, 291C4 (0 .96) and MRL +/+ (0.95), are more
homologous to the pB6.3R1 probe than are the others and are both members
ofgroup IV . Since both clones, 291C4 (0 .28) and MRL +/+ (0.23), also display
similar intensity ratios with the 460-42 probe, they may use the same germline
Vn gene . Three other clones (2521-16, 146C6, and 294D6) display similar ho-
mology with thepB6.3R1 probeandare probably encoded by another member(s)
of the 36-60 V,, family, even though they are each members of different binding
groups . Clone 154115 (group 111) also hybridized with both 36-60 family probes
(data not shown) .
Three clones exhibited crosshybridization with probes from two different
families, 36-60 and, to a lesser extent, J558 . A representative scan ofone clone
in group I (295A4) is shown in Fig . 3 . The lower scan in Fig, 3 exemplifies
negative hybridization with theQ52 probe. The histograms in Fig. 4 represent
intensities of hybridization with the V family probes and the CA control probe
for each ofthe three clones that exhibitedV crosshybridization . Numbers below
each set of histograms represent the ratio of hybridization intensities obtained
with the V family probes compared with the intensities obtained with the CA.
probe. A summary of antigen-binding specificities and the V family used by all
clones is presented in Table IV . Data from these experiments indicate that the
germline codes for a majority (6/9) of the anti-IgG clones represented in our
panel are clustered in a small genomic locus containing only five homologous V,,
gene segments . The other three clones may also have derived their codes fromARANT ET AL .
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FIGURE 3.
￿
Representative densitometric scans of autoradiograms from clone 295A4 that
hybridized with Cli probe (- - -) and probes from two V families (-): pB6.3R1 (36-60
family probe, top) andpBV,t1558 (J558 family probe, bottom) . Top right shows autoradiogram
dots and far right side delineates the antigen-binding specificity ofthe clone .
FIGURE 4 .
￿
Histograms represent hybridization intensities of the three clones that displayed
crosshybridization with probes from two different families (36-60 andJ558) . Hybridized filters
were exposed as follows : pB6.3R1 (2 .3 kb), 16 h; J558 (1 .0 kb), 24 h; 460-42 (0.4 kb), 48 h ;
and Cj (1 .0 kg), 15 h. Numbers below the abscissa represent comparisons of hybridization
intensity with V family probes to intensity of hybridization with the Cw probe on the same
filters used for hybridization to the V family probe.
the 36-60 VH family as well, but since they also crosshybridize with J558, we
cannot be certain of their origin .
Discussion
MRL/Mp lpr/lpr mice develop an aggressive autoimmune disease character-
ized by immune complex-mediated glomerulonephritis, polyarteritis, and pan-
nus-forming erosive synovitis . Associated with the autoimmune pathology are1294
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TABLE IV
Summary of V Family Usage and Specificitiesfor Anti-IgG Antibodies
* Numbersin parentheses indicate bindingto proteolytic fragments of mouse IgGand heterologous
IgG expressedas percent bindingcompared with mouse IgG control (+4, >75%;+3, 50-74% ; +2,
25-94%; +1, 10-24%).
H, human; Gp, guinea pig; G, goat; P, pig; R, rat; Ho, horse; C, cow; Rb, rabbit.
polyclonal B cell activation (38) and the production of multiple autoantibodies,
including those directed against DNA and IgG (24, 25). The precise relationship
ofautoantibody production to thedevelopmentofautoimmune disease is unclear.
In the MRL/Mp lpr/lpr mouse, the presence of the lpr gene, which is responsible
for generalized lymphoproliferation and accelerated onset of autoimmune dis-
ease, is also associated with enhanced autoantibody expression (26). The intro-
duction of the lpr gene into nonautoimmune mice or stimulation of normal
strains with LPS results in lymphoproliferation, polyclonal B cell activation, and
the production of anti-DNA and RF antibodies without autoimmune pathology
(e. g., glomerulonephritis; 39-41) . However, the simultaneous administration of
two immunostimulators, lpr and LPS, to mouse strains with otherwise normal
genetic backgrounds results in severe autoimmune manifestations in addition to
autoantibody production (42). Taken together, these studies indicate that germ-
line genes that can encode autoantibodies associated with autoimmune pathology
are present in normal mice .
There is little information concerning the molecular basis of autoantibody
production. Amino acid and nucleotide sequence analysis of a limited number
of anti-DNA mAbs derived from autoimmune mice revealed the use of V gene
segments highly homologous to germline genes in normal mice encoding anti-
bodies directed against PC or to the hapten DNP (43, 44). These data cast doubt
on the likelihood of anti-DNA autoantibodies beingderivedfrom a unique subset
of V genes. To investigate this issue in another autoantibody system, we have
constructed a panel of hybridomas secreting antibodies with anti-IgG activity
from unmanipulated spleen cells of MRL/Mp lpr/lpr and the congeneic strain,
MRL/Mp +/+ mice. We obtained eight clones from the lpr/lpr strain and one
from the +/+ strain and analyzed the binding of each antibody to proteolytic
Group Clones V Family Fragments IgG sub-
classes Heterologous IgG DNA
1 2521-16 35-60 Fc (+4)* 2a, 1, 3 H (+2) Z
295A4 36-60/J558 Fc (+4) 2a, 3 None Z, B
II 253132 36-30/J558 Fc (+1) 2a, 3 G, P, H, Rb (+4) 0
295C6 30-60/J558 Fc (+1) 2a, 3 Ho, Gp, C (+4) 0
III 146C6 36-60 Fab (+3) -
(Fab')2 (+2) - None 0
154135 36-60 Fab (+3) -
(Fab')2 (+2) - None 0
IV 291C4 36-60 Intact IgG 2a None 0
MRL +/+ 36-60 Intact IgG 3 None 0
294D6 36-60 (Fab')2 (+4) - Rb (+4) 0ARANT ET AL.
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fragments of mouse IgG [Fc, Fab, (Fab')2], mouse IgG subclasses, and heterolo-
gous IgG, and determined which V gene family was used to encode these anti-
IgG antibodies. We found that the anti-IgG antibodies produced by these clones
bound a heterogeneous array of epitopes on the IgG molecule. This pattern is
similar to that seen with anti-IgG antibodies associatedwith human RA, including
the existence of a subset that also bound to DNA (37). Interestingly, the two
IgM X clones that were derived from young mice, 154115 (4 wk) and 146C6 (8
wk), recognized the Fab/(Fab')2 portion of the IgG molecule and exhibited a
much more restricted binding specificity (i. e., to murine IgG alone) than the
clones generated from older mice. Autoantibodies that bind the (Fab')2 portion
of human IgG have also been detected in sera from RA patients (45).
Since little is known about the molecular mechanisms underlying RF produc-
tion in RA, we initiated a study with our clones from the MRL mouse to
determine which families of Vn gene segments contributed codes for this heter-
ogeneous population ofautoantibodies. Our finding that the VH portion ofthese
antibodies was encoded predominantly by members of the 36-60 family regard-
less of the binding specificity was striking, because the 36-60 family comprises
only five members, whileJ558 has at least 60 and probably 1,000 members (46).
The frequency of IgG-binding hybridomas generated from the fusions of un-
manipulated spleen cells from 4- and 8-wk-old mice was ^-10%. Although many
of the hybridomas were unstable and could not be rescued for analysis, if a
similar proportion of those clones that were not analyzed was also encoded by
the 36-60 family, then therepresentation ofthat family isclearly disproportionate
to its size. Recent studies (47) using IgM-secreting hybridomas derived from 5-
mo-old MRL/Mp 1pr/1pr mice showed that at least three other V families (J558,
Q52, and 7183) can encode antibodies that react with IgG at later stages of
development. Since the mice from which we prepared the hybridomas were
young and raised under pathogen-free conditions, and since they displayed only
early disease manifestations (24),3 we feel that this pattern ofpreferential 36-60
Vn expression may well reflect the germline genetic contribution to subsequent
immunopthology in these animals.
Comparisonofthe ratio ofhybridization intensitiesobtained withthe CI probe
to the intensities obtained using the 36-60 probe suggested that at least two gene
segments of the 36-60 family were represented in our panel of anti-IgG antibod-
ies.
Two clones, 291C4 and MRL +/+, probably use the same germline gene,
since their ratios of hybridization intensities of CA to 36-60 (pB6 .3R1) are 0.96
and 0.95, respectively. Another gene(s) in the 36-60 family is likely to encode
252H6 (0.46), 146C6 (0.49) and 294D6 (0.45); the numbers in parentheses are
the ratios for the pB6.3R1 probe. It is difficult to determine whether or not the
remaining three clones (295A4, 253B2, and 295C6) used yet another member
ofthe 36-60 genefamily, since they all showed some degree ofcrosshybridization
with the probe from the J558 family. The crosshybridization these clones
exhibited with both 36-60 and J558 probes is not readily explainable. A trivial
explanation would be that the hybridomas were biclonal. However, the repro-
'Fine, J. D., F. X. O'Sullivan, S. Gay, and W. J. Koopman. Ultrastructural localization of skin
immunoreactants in the autoimmune animal strain MRL/lpr. Manuscript submitted for publication.1296
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ducibility ofthese results despite five subclonings ofeach ofthese clones renders
this explanation unlikely. Alternative explanations include somatic mutations
involving random base pair substitutions or gene conversion between a 36-60
sequence and a J558 sequence .
Recent evidence suggests that the location ofa V gene family within the V,,
locus influences itstime ofexpression during development, withthose Vfamilies
most proximal to the CA region being expressed earliest (32, 48). Since the 36-
60 family is one of the families most distal to the CA locus, clonal expression of
36-60-encoded products may occur later in B cell ontogeny. It is conceivable
that aberrations in the programmed expression of V gene families could con-
tribute to abnormalities in the B cell repertoire characteristic ofautoimmunity.
Alternatively, similar abnormalities might be anticpated if defects occurred in
proteins (antiidiotype network) or cells (Th or Ts) that regulate VH gene family
expression .
Since a subset of MRL lpr/lpr T cells that display a variety of functional and
phenotypic abnormalities (49-54) is the major cell population responsible for the
massive lymphadenopathy and splenomegaly seen in this strain it is possible that
regulation of products contributes to the immunopathology in these animals.
Neonatal thymectomy of MRL lpr/lpr mice markedly reduced lymphoprolifer-
ation of the phenotypically abnormal Tcell population, decreased autoantibody
concentrations, and prolonged life (55, 56), thus indicating a major role for T
cells in the onset and severity of the autoimmune syndrome. The proliferation
of abnormal T cells may create an imbalance between T cell suppression and
enhancement and facilitate expansion of the autoreactive clones.
Our autoantibody-producing hybridomas derived from autoimmune mice do
not use a unique setofV genes. Rather, they use V genes homologous to those
present in normal mouse strains that maybe used for theproduction ofantibodies
directed against exogenous antigens. In this regard, murine anti-DNA antibodies
have been shown to share idiotypic markers with Ig lacking autoreactivity (57),
and some anti-DNA mAbs from autoimmune mice have been shown (58) to bind
to bacterial constituents. These results indicate that antibodies directed against
environmental antigens may crossreact with self determinants. Alternatively,
autoantibodies may be derived by somatic mutation ofgermline genes encoding
antibodies directed against exogenous antigens. Direct evidence for this comes
from a recent report of an anti-DNA antibody arising from a single point
mutation in the V,, gene of an 5107 myeloma cell line that originally produced
an antibody reactive with phosphorylcholine (59). Thus, a minor alteration in a
germline gene may lead to the generation of an autoreactive clone.
In summary, our results indicate that anti-IgG antibodies spontaneously ex-
pressed in young autoimmune MRL mice are preferentially encoded by genes
residing within the small 36-60 V,, gene family. These data raise the possibility
that human autoantibody counterparts occurring in rheumatic disease may also
use a restricted number ofgermline variable region genes.
Summary
Antibodiesdirectedagainst IgGand DNAare found in the seraofautoimmune
MRL/Mp lpr/lpr mice. Little is known ofthe molecular mechanisms underlyingARANT ET AL.
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expression of such autoantibodies. We have investigated the binding diversity
and pattern of V gene expression in a panel of murine anti-IgG antibodies . We
constructed eight hybridoma clones secreting IgM antibodies that bound to
mouse IgG by using spleen cells from MRL/Mp lpr/lpr mice varying in age from
4 to 15 wk; one clone was derived from a 32-wk-old MRL +/+ mouse. The
monoclonal IgM products exhibited varying bindingspecificities for intact mouse
IgG, fragments of mouse IgG [Fc, Fab, (Fab')2], and heterologous IgG. Two of
these antibodies crossreacted with B and/or Z DNA. Probes from seven of eight
identified mouse V gene families (7183, S107, Q52, J558, J606, 36-60, and
3609) were hybridized under high-stringency conditions with cytoplasmic RNA
blots from each clone. Six clones hybridized only with the probe from the five-
member 36-60 family. The remaining three clones crosshybridized with the 36-
60 probe and the probe from the 60 member J558 family, perhaps reflecting
somatic mutation from the original germline V,, gene resulting in recognition by
a probe from another family, in addition to theprobe from the original germline
family . Our results indicate that spontaneous MRL lpr/lpr anti-IgG antibodies
are encoded predominantly by the 36-60 VH gene family and imply a nonrandom
selection of this V,, gene family in the production of these antibodies .
We thank Dr. Tony Marion, Dr. Mary Ann Accavitti, andJohn Morgan for technical
advice; Dr. Russell Lindsey for guidance in isolator maintenance of mice; and Ms. Sandra
Reid forassistance in preparation of this manuscript.
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